BU-NOT-SET

CONTACT US
Gene therapy manufacturing journey
  • Biologics
Gene therapy manufacturing journey
Insight
Pushing boundaries in mRNA vaccine manufacturing
  • Biologics
Pushing boundaries in mRNA vaccine manufacturing
Insight
Nitrosamines analysis
  • Analytical chemistry
Nitrosamines analysis
Fact sheet
Enabling oral solid dosage form delivery of biologics
  • Biologics
  • Drug substance
oral biologics
Insight
Plasmid DNA manufacturing capabilities
  • Biologics
plasmid DNA manufacturing
Fact sheet
Leveraging analytics throughout development and manufacture to achieve commercial success
  • Analytical chemistry
  • Drug substance
development
Insight
2,300 solar panels installed at Recipharm’s Holmes Chapel
  • Sustainability
solar panels
Insight
Analysing prebiotic oligosaccharides for future product innovation
  • Analytical chemistry
  • Drug substance
Workers
White paper
Enhancing sterile processing for future vaccine programs
  • Industry trends
  • Manufacturing
Manufacturing
Insight
Poster
  • Drug substance
Innovative ALS Tablet Development
Insight
  • Drug product
  • Manufacturing
How Blow-fill-seal (BFS) technology may be a superior alternative to glass vials during the early stages of a development project
White paper
  • Biologics
Product Quality in the Advanced Therapies Manufacturing
Insight
  • Biologics
Navigating ATMP fill and finish complexities
Insight
  • Biologics
The power of analytics and AI in the era of continuous RNA manufacturing
Insight
  • Biologics
Reimagining the RNA manufacturing space: An interview with ReciBioPharm’s leaders
Insight
  • Biologics
Unlocking the potential of mRNA: Inside ReciBioPharm's Watertown site
Insight
  • Biologics
Industry 5.0 in action: AI-driven continuous manufacturing for RNA therapeutics
Insight
  • Drug product
  • Manufacturing
Choosing the optimal container format for sterile drug products